stockrowICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
Follow ICUI
Alert me
ICU Medical, Inc. (ICUI) EPS (diluted)
ICU Medical, Inc.'s EPS (diluted) for fiscal 2025 was $0.03, compared with −$4.83 in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.39. Over the past ten years it has ranged from −$4.83 (fiscal 2024) to $4.74 (fiscal 2021); the current reading is higher than 36% of that period. ICU Medical, Inc. ranks 13th of 47 Medical Instruments & Supplies companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $0.03 | — |
| FY2024 | −$4.83 | — |
| FY2023 | −$1.23 | — |
| FY2022 | −$3.11 | — |
| FY2021 | $4.74 | 17.91% |
| FY2020 | $4.02 | (14.29%) |
| FY2019 | $4.69 | 252.63% |
| FY2018 | $1.33 | (59.57%) |
| FY2017 | $3.29 | (10.11%) |
| FY2016 | $3.66 | 34.07% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $1.07 | 40.79% |
| Jun 2026 | $0.76 | (36.67%) |
| Mar 2026 | $1.20 | — |
| Dec 2025 | −$0.64 | — |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| NVST Envista Holdings Corporation compare | $3.92 |
| MMSI Merit Medical Systems, Inc. compare | $2.66 |
| ICUI ICU Medical, Inc. | $2.39 |
| STVN Stevanato Group S.p.A. compare | $0.59 |
| ATRC AtriCure, Inc. compare | $0.30 |
| WRBY Warby Parker Inc. compare | $0.06 |
| MMED MiniMed Group, Inc. compare | −$0.59 |
| PLSE Pulse Biosciences, Inc compare | −$1.21 |
| TFX Teleflex Incorporated compare | −$23.29 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on ICUI
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement